Trastuzumab beyond progression in HER2-positive advanced breast cancer: The Royal Marsden experience

MLA

Waddell, T., et al. “Trastuzumab beyond Progression in HER2-Positive Advanced Breast Cancer: The Royal Marsden Experience.” British Journal of Cancer, vol. 104, no. 11, Apr. 2011, pp. 1675–79. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....46f4ce17477c9f4dfdc3d01c7678d206&authtype=sso&custid=ns315887.

APA

Waddell, T., Kotsori, A., Constantinidou, A., Yousaf, N., Ashley, S., Parton, M., Allen, M., Starling, N., Papadopoulos, P., O’Brien, M., Smith, I. E., & Johnston, S. L. (2011). Trastuzumab beyond progression in HER2-positive advanced breast cancer: The Royal Marsden experience. British Journal of Cancer, 104(11), 1675–1679.

Chicago

Waddell, T., A. Kotsori, Anastasia Constantinidou, N. Yousaf, Sue Ashley, M. Parton, M. Allen, et al. 2011. “Trastuzumab beyond Progression in HER2-Positive Advanced Breast Cancer: The Royal Marsden Experience.” British Journal of Cancer 104 (11): 1675–79. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....46f4ce17477c9f4dfdc3d01c7678d206&authtype=sso&custid=ns315887.